New CEO commentary — “Redefining aging with HoloMonitor”

In the CEO commentary “Redefining aging with HoloMonitor” Peter Egelberg comments on the promising research results that were recently reported by Australian television. By studying primitive bacteria researchers at Queensland University of Technology in Australia have been able to develop a new drug that has the potential to dramatically slow the aging process. The newscast reports that by using the company’s cell analyzer HoloMonitor the researchers were able to see how old and damaged cells became young.